AstraZeneca

Open: 63.25 Close: 63.59 Change: 0.34

Stop reading the whole internet to decide if you want to invest in AstraZeneca.

Are looking for the most relevant information about AstraZeneca? Investor spend a lot of time searching for information to make investment decisions in AstraZeneca. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, Astra, vaccine, Cellectis, gene, Zeneca, and the most common words in the summary are: astrazeneca, news, cellectis, company, vaccine, investment, pharmaceutical, . One of the sentences in the summary was: 25 genetic targets have been exclusively reserved for Astra Zeneca, from which up to …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

AstraZeneca to invest $245m in cellectis - european pharmaceutical manufacturer. 25 genetic targets have been exclusively reserved for Astra Zeneca, from which up to 10 candidate products could be explored.

Today's News

AstraZeneca announces multi-year partnership with nhl and nhlpa hockey fights cancer initiative. Astra Zeneca is proud to support Hockey Fights Cancer, which aims to give hope and inspire those who are living with cancer. AstraZeneca to invest $245m in cellectis - european pharmaceutical manufacturer. 25 genetic targets have been exclusively reserved for Astra Zeneca, from which up to 10 candidate products could be explored. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The companys primary listing is on the London Stock Exchange. AstraZeneca rejected a final offer from Pfizer of £55 per share, valued the company at £69.4   billion (US$117   billion) In October 2013, Astra Zeneca announced it would acquire biotech oncology company Spirogen for around US$440 million. In May 2014, company announced a number of collaborations worth an estimated US$1.8 billion with Ariesfinalcohol API Rate jab Tai partlyurring########754 addition AstraZeneca has its headquarters in Cambridge, United Kingdom, and main R&D centres are in Cambridge (UK), Gaithersburg (Maryland, US), Gothenburg (Sweden) and Warsaw (Poland) AstraZevria is a member of the Personalized Medicine Coalition, a medical research advocacy group. AstraZeneca entered into a preliminary agreement with the U.K. The key difference seems to be that AstraZecas China president said that the company aims to be a patriotic company in China. AstraZeneca spins off autoimmune drugs into new biotech company. Oxford vaccine researchers have found winning formula, AstraZeneca chief says A new pharma king? Astrazeneca approaches Gilead about potential merger AstraZeneca to invest $245m in Cellectis to strengthen gene therapy portfolio. Partnership will leverage Cellects gene editing technologies and manufacturing capabilities to develop up to 10 novel cell and gene therapy candidate products. Astrazeneca is expected to post earnings of $0.79 per share for the current quarter, representing a year-over-year change of -6%. The Zacks Large Cap Pharmaceuticals industry, to which Astrazenecates belongs, has lost 4.2% over this period. The size of the recent change in the consensus estimate, along with three other factors. AstraZeneca is seeking FDA approval for a nasal spray flu vaccine that could be administered by yourself from the comfort of your home. Known as FluMist Quadrivalent, the technology behind the nasal spray vaccine is not new. Sweden is latest country to stop using AstraZeneca vaccine. Cellectis will receive an initial payment of $105m from Astra. AstraZeneca to invest $245 million in Cellectis to boost gene therapy prospects. Astra Zeneca shares were up 1.0% at 10,351.32 pence. Cellectis announces strategic collaboration and investment agreements with AstraZeneca. The company aims to have Flumist Quadrivalent available for delivery directly to individual homes, an innovative approach to increasing ease of access. AstraZeneca and Cellectis will leverage their pioneering research in gene editing and cell therapies. No prospectus will be established in France or outside of France. AstraZeneca has a relatively large IR team of eight (including Barnett), allowing a ‘divide and conquer approach to the sell side’ AstraZecas has a high concentration of shareholders in Stockholm and London, while investors in Shanghai and Tokyo proactively engage with the company. AstraZeneca PLC ADR rises Tuesday, still underperforms market. NASDAQ Composite Index COMP rising 0.48% to 12,851.24. Dow Jones Industrial Average DJIA rises 0.38%.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

How much time have you spent trying to decide whether investing in AstraZeneca? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, Astra, vaccine, Cellectis, gene, Zeneca, and the most common words in the summary are: astrazeneca, news, cellectis, company, vaccine, investment, pharmaceutical, . One of the sentences in the summary was: 25 genetic targets have been exclusively reserved for Astra Zeneca, from which up to 10 candidate products could be explored.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #news #cellectis #company #vaccine #investment #pharmaceutical.